ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,017,157 | +141679.2% | 440,076 | +52.6% | 0.05% | -4.1% |
Q4 2022 | $6,360 | -99.8% | 288,316 | +16.0% | 0.05% | +44.1% |
Q3 2022 | $4,068,000 | -2.0% | 248,510 | +0.0% | 0.03% | 0.0% |
Q2 2022 | $4,149,000 | +129.9% | 248,460 | +88.3% | 0.03% | +161.5% |
Q1 2022 | $1,805,000 | -14.7% | 131,957 | +2.3% | 0.01% | -18.8% |
Q4 2021 | $2,115,000 | -38.1% | 129,017 | +11.0% | 0.02% | -23.8% |
Q3 2021 | $3,416,000 | +3.6% | 116,230 | -3.3% | 0.02% | +5.0% |
Q2 2021 | $3,296,000 | -8.8% | 120,192 | +48.9% | 0.02% | -9.1% |
Q1 2021 | $3,615,000 | +17.8% | 80,705 | +44.6% | 0.02% | +15.8% |
Q4 2020 | $3,070,000 | +274.8% | 55,811 | +91.5% | 0.02% | +216.7% |
Q3 2020 | $819,000 | +25.0% | 29,146 | +12.7% | 0.01% | +20.0% |
Q2 2020 | $655,000 | +21.1% | 25,866 | -17.0% | 0.01% | 0.0% |
Q1 2020 | $541,000 | -9.2% | 31,151 | +15.1% | 0.01% | 0.0% |
Q4 2019 | $596,000 | +64.2% | 27,065 | -3.9% | 0.01% | +66.7% |
Q3 2019 | $363,000 | +38.0% | 28,155 | +35.2% | 0.00% | +50.0% |
Q2 2019 | $263,000 | – | 20,826 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |